Page 4 - Patricia Hurter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patricia hurter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patricia Hurter Today - Breaking & Trending Today

Lyndra Therapeutics Closes $60.5M Series C Financing


Lyndra Therapeutics Closes $60.5M Series C Financing
Lyndra Therapeutics, a Watertown, Mass.-based clinical-stage biotechnology company pioneering a novel technology platform that transforms daily pills into once-weekly to monthly oral treatment options, closed a $60.5m Series C financing.
The round was led by new investor, AIG Investments, an affiliate of American International Group with participation from new investors Yipinhong Pharmaceutical (USA) Limited, Limitless Ventures and the Catalytic Impact Foundation with ImpactAssets, and existing investors Polaris Partners, Invus, Quark Venture, Mass General Brigham Ventures, HOPU Investments, and Gilead Sciences, Inc.
The company intends to use the funds to advance its lead product candidate into pivotal trials as they prepare for commercialization in the U.S., expand its central nervous system (CNS) pipeline assets and actively evaluate high value partnerships across a broad range of disease states. ....

United States , Patricia Hurter , Amy Schulman , Yipinhong Pharmaceutical United States , American International Group , Gilead Sciences Inc , Impact Foundation , Lyndra Therapeutics , Yipinhong Pharmaceutical , Limitless Ventures , Catalytic Impact Foundation , Polaris Partners , Quark Venture , Mass General Brigham Ventures , Gilead Sciences , Chief Executive Officer , Executive Chair , ஒன்றுபட்டது மாநிலங்களில் , ஆமி ஸ்சுழ்மான் , அமெரிக்கன் சர்வதேச குழு , கிலியட் அறிவியல் இன்க் , தாக்கம் அடித்தளம் , வரம்பற்றது முயற்சிகள் , போழரிச் கூட்டாளர்கள் , குவார்க் துணிகர , கிலியட் அறிவியல் ,

Biotech and medical device companies lining up plans to offer vaccination sites for their employees


Life sciences companies face supply constraints as they look to offer vaccination sites for their employees
Despite daunting logistics, many employers are eager to provide shots to workers
By Jon Chesto Globe Staff,Updated February 24, 2021, 6:43 p.m.
Email to a Friend
Empty vials of the Pfizer-BioNTech COVID-19 vaccine.John Locher/Associated Press
As the Baker administration plans for the next expansion of vaccinations in Massachusetts, a major business sector has been getting ready to help distribute doses to potentially thousands
of its employees.
Thanks in part to industry lobbying, life-sciences employees were included in a group of essential workers that are due to be eligible for vaccines in Phase 2 of the rollout. These workers could be eligible for inoculations as soon as March, along with K-12 teachers and employees of other selected workplaces deemed essential, such as day-care centers, restaurants, funeral homes, and utilities. ....

United States , South Shore , Boston University , Patricia Hurter , Marylou Sudders , Jim Rooney , David Lucchino , Brian Johnson , Chris Anderson , Richard Doherty , Jodie Morrison , David Hamer , Kate Reilly , Association Of Independent Colleges , Massachusetts Medical Device Industry Council , Fidelity Investments , Greater Boston Chamber , Massachusetts High Technology Council On , Massachusetts Medical Device Industry , Frequency Therapeutics , Blue Cross Shield , Massachusetts High Technology Council , Independent Colleges , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கரை , போஸ்டன் பல்கலைக்கழகம் ,